Related Experiment Video

Updated: Aug 20, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Signaling multiplex of the epidermal growth factor receptor

Gerald M Higa1

  • 1Mary Babb Randolph Cancer Center, School of Pharmacy, West Virginia University, Morgantown, WV 26506-9520, USA. ghiga@hsc.wvu.edu

Expert Review of Anticancer Therapy
|December 21, 2004
PubMed

Insights

This review details cell signaling via receptor tyrosine kinases, focusing on the epidermal growth factor receptor and its targeted therapy, cetuximab.

Area of Science:

  • Cellular biology and signal transduction pathways.
  • Molecular mechanisms of transmembrane receptor tyrosine kinases.

Background:

  • Receptor tyrosine kinases (RTKs) are crucial for normal cell development and physiological processes.
  • Dysregulation of RTKs is linked to uncontrolled cell growth in cancers.
  • Significant advancements have been made in understanding RTK signaling over the last 30 years.

Purpose of the Study:

  • To review the sophisticated mechanistic understanding of cell signaling through RTKs.
  • To focus on the epidermal growth factor receptor (EGFR) as a key RTK.
  • To discuss cetuximab, a monoclonal antibody targeting EGFR.

Main Methods:

  • Literature review of mechanistic studies on RTK signaling.
  • Focus on research pertaining to the epidermal growth factor receptor.
  • Examination of data regarding cetuximab's role in targeting EGFR.

Main Results:

  • Cellular communication relies on internalizing and deciphering extracellular signals.
  • RTKs are vital for normal development but implicated in cancer pathogenesis.
  • Cetuximab is the sole approved monoclonal antibody for EGFR targeting.

Conclusions:

  • Understanding RTK signaling is critical for both normal physiology and cancer treatment.
  • EGFR is a significant target in cancer therapy.
  • Cetuximab represents a key therapeutic strategy for EGFR-mediated diseases.

More Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...